About us

Our vision and values

Our vision:

“A world free from fear of untreatable infections.“


Antibiotic resistance is a complex and ever-changing phenomenon deeply influenced by microbial ecology, human behavior and globalization. ReAct was one of the first international networks to articulate the complex nature of antibiotic resistance and its drivers, calling for a holistic view of the problem and solutions that engage all of society.

  • We believe that access to affordable and effective treatment and prevention of bacterial infections is part of everyone’s right to health.
  • Our vision is “A world free from fear of untreatable infections“.
  • We believe that change towards this vision will depend on engaging with social movements, civil society, community- and consumer organizations, academia, policy makers and those individuals, networks or institutions that generate and analyze health-related knowledge.


ReAct works across disciplines to identify and promote best practices, innovative and ecologically grounded solutions to contain antibiotic resistance that contribute to universal health coverage, poverty reduction and global development.

  • We view antibiotic effectiveness as an essential public good and as a potentially non-renewable resource.
  • We promote context-specific solutions to account for the diversity of systems of health care, cultural practices, resource availability, geography and other relevant factors.
  • We promote an ecosystem approach to antibiotic resistance to replace the dominant war metaphor of bacteria as our ‘enemy’, with an understanding of the essential role of microbes and microbial ecology in the health of humans.
  • We advocate for the need to see infection prevention and sustainable access to effective antibiotics as a critical component in achieving several of the Sustainable Development Goals.
  • We support access for all in need while working for maximum and context specific conservation efforts of existing and new antibiotics.

We are independent of the private pharmaceutical industry and do not accept any financial support from it.